{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:53:59Z","timestamp":1768276439907,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T00:00:00Z","timestamp":1427414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s40259-015-0120-y","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T14:32:39Z","timestamp":1427466759000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacologic Vitreolysis with Ocriplasmin: Rationale for Use and Therapeutic Potential in Vitreo-Retinal Disorders"],"prefix":"10.1007","volume":"29","author":[{"given":"Matin","family":"Khoshnevis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,27]]},"reference":[{"key":"120_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199801000-00001","volume":"18","author":"J Sebag","year":"1998","unstructured":"Sebag J. Pharmacologic vitreolysis (Guest Editorial). Retina. 1998;18:1\u20133.","journal-title":"Retina."},{"key":"120_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200202000-00001","volume":"22","author":"J Sebag","year":"2002","unstructured":"Sebag J. Is pharmacologic vitreolysis brewing? (Guest Editorial). Retina. 2002;22:1\u20133.","journal-title":"Retina."},{"key":"120_CR3","first-page":"473","volume":"103","author":"J Sebag","year":"2005","unstructured":"Sebag J. Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc. 2005;103:473\u201394.","journal-title":"Trans Am Ophthalmol Soc."},{"key":"120_CR4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/IAE.0b013e3181ac7b3c","volume":"29","author":"J Sebag","year":"2009","unstructured":"Sebag J. Pharmacologic vitreolysis\u2014premise and promise of the first decade (Guest Editorial). Retina. 2009;29:871\u20134.","journal-title":"Retina."},{"issue":"2","key":"120_CR5","first-page":"52","volume":"7","author":"J Sebag","year":"2010","unstructured":"Sebag J. The emerging role of pharmacologic vitreolysis. Retinal Physician. 2010;7(2):52\u20136.","journal-title":"Retinal Physician."},{"key":"120_CR6","doi-asserted-by":"crossref","unstructured":"Sebag J. Pharmacologic vitreolysis. In: Sebag J, editor. Vitreous in health and disease, chapter VI.A. New York: Springer; 2014.","DOI":"10.1007\/978-1-4939-1086-1_47"},{"key":"120_CR7","unstructured":"Sebag J, Yee KMP. Vitreous\u2014from biochemistry to clinical relevance. In: Tasman W, Jaeger EA, editors. Duane\u2019s foundations of clinical ophthalmology, vol. 1, Ch 16. Philadelphia: Lippincott Williams & Wilkins; 2007."},{"key":"120_CR8","doi-asserted-by":"crossref","unstructured":"Crafoord S, Ghosh F, Sebag J. Vitreous biochemistry and artificial vitreous. In: Sebag J, editor. Vitreous\u2014in health and disease, Ch I.F. New York: Springer; 2014.","DOI":"10.1007\/978-1-4939-1086-1_6"},{"key":"120_CR9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00417-004-0980-1","volume":"242","author":"J Sebag","year":"2004","unstructured":"Sebag J. Anomalous PVD\u2014a unifying concept in vitreo-retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2004;242:690\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"120_CR10","doi-asserted-by":"crossref","unstructured":"Sebag J. Vitreous anatomy, aging, and anomalous posterior vitreous detachment. In: Dartt, Besharse, Dana, editors. Encyclopedia of the eye. Oxford: Elsevier; 2010. pp. 307\u2013315.","DOI":"10.1016\/B978-0-12-374203-2.00256-6"},{"issue":"1","key":"120_CR11","first-page":"212","volume":"27","author":"DH Steel","year":"2013","unstructured":"Steel DH, Lotery AJ. Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment. Eye. 2013;27(1):212.","journal-title":"Eye."},{"issue":"4","key":"120_CR12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2004.11.035","volume":"139","author":"A Gandorfer","year":"2005","unstructured":"Gandorfer A, Rohleder M, Grosselfinger S, Haritoglou C, Ulbig M, Kampik A. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction. Am J Ophthalmol. 2005;139(4):638\u201352.","journal-title":"Am J Ophthalmol."},{"key":"120_CR13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ajo.2007.07.024","volume":"144","author":"I Krebs","year":"2007","unstructured":"Krebs I, Brannath W, Glittenberg K, Zeiler F, Sebag J, Binder S. Posterior vitreo-macular adhesion: a potential risk factor for exudative age-related macular degeneration. Am J Ophthalmol. 2007;144:741\u20136.","journal-title":"Am J Ophthalmol."},{"key":"120_CR14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2009.01.014","volume":"148","author":"C Robison","year":"2009","unstructured":"Robison C, Krebs I, Binder S, Barbazetto IA, Kostolis AI, Yannuzzi LA, Sadun AA, Sebag J. Vitreo-macular adhesion in active and end-stage age-related macular degeneration. Am J Ophthalmol. 2009;148:79\u201382.","journal-title":"Am J Ophthalmol."},{"key":"120_CR15","unstructured":"Parel JMP. The history of vitrectomy. In: Sebag J, editor. Vitreous in health and disease, Ch V.B.1. New York: Springer; 2014."},{"issue":"3","key":"120_CR16","first-page":"22","volume":"32","author":"JMP Parel","year":"2014","unstructured":"Parel JMP, Sebag J. Recalling the development of vitreo-retinal therapeutics from vitrectomy to pharmacologic vitreolysis. Retina Times. 2014;32(3):22\u20136.","journal-title":"Retina Times"},{"key":"120_CR17","doi-asserted-by":"crossref","unstructured":"Tezel TH, Del Priore LH, Kaplan HJ: Pharmacologic vitreolysis with purified dispase (Vitreolysin\u2122). In: Sebag J, editor. Vitreous\u2014in health and disease, Ch VI.G. New York: Springer; 2014.","DOI":"10.1007\/978-1-4939-1086-1_55"},{"issue":"11","key":"120_CR18","first-page":"4629","volume":"41","author":"LA Liotta","year":"1981","unstructured":"Liotta LA, Goldfarb RH, Brundage R. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981;41(11):4629\u201336.","journal-title":"Cancer Res."},{"issue":"3","key":"120_CR19","first-page":"506","volume":"28","author":"T Kohno","year":"1987","unstructured":"Kohno T, Sorgente N, Ishibashi T. Immunofluorescent studies of fibronectin and laminin in the human eye. Investig Ophthalmol Vis Sci. 1987;28(3):506\u201314.","journal-title":"Investig Ophthalmol Vis Sci."},{"issue":"3","key":"120_CR20","first-page":"496","volume":"27","author":"T Kohno","year":"1983","unstructured":"Kohno T, Sorgente N, Patterson R, Ryan SJ. Fibronectin and laminin distribution in bovine eye. Jpn J Ophthalmol. 1983;27(3):496\u2013505.","journal-title":"Jpn J Ophthalmol."},{"issue":"7","key":"120_CR21","first-page":"1986","volume":"32","author":"SR Russell","year":"1991","unstructured":"Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane. Investig Ophthalmol Vis Sci. 1991;32(7):1986\u201395.","journal-title":"Investig Ophthalmol Vis Sci."},{"issue":"6","key":"120_CR22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archopht.1993.01090060139038","volume":"111","author":"TC Verstraeten","year":"1993","unstructured":"Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111(6):849\u201354.","journal-title":"Arch Ophthalmol."},{"issue":"1","key":"120_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00006982-199901000-00009","volume":"19","author":"T Hikichi","year":"1999","unstructured":"Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19(1):55\u20138.","journal-title":"Retina."},{"issue":"1","key":"120_CR24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3341\/kjo.2004.18.1.35","volume":"18","author":"NJ Kim","year":"2004","unstructured":"Kim NJ, Yu HG, Yu YS, Chung H. Long-term effect of plasmin on the vitreolysis in rabbit eyes. Korean J Ophthalmol. 2004;18(1):35\u201340.","journal-title":"Korean J Ophthalmol."},{"issue":"1","key":"120_CR25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bjo.85.1.6","volume":"85","author":"A Gandorfer","year":"2001","unstructured":"Gandorfer A, Putz E, Welge-L\u00fc\u00dfen U, Gr\u00fcterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85(1):6\u201310.","journal-title":"Br J Ophthalmol."},{"issue":"1","key":"120_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9394(01)01252-1","volume":"133","author":"A Gandorfer","year":"2002","unstructured":"Gandorfer A, Priglinger S, Schebitz K, et al. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol. 2002;133(1):156\u20139.","journal-title":"Am J Ophthalmol."},{"issue":"1","key":"120_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s004170100351","volume":"240","author":"X Li","year":"2002","unstructured":"Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol. 2002;240(1):56\u201362.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"2","key":"120_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archopht.123.2.209","volume":"123","author":"A Uemura","year":"2005","unstructured":"Uemura A, Nakamura M, Kachi S, et al. Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy. Arch Ophthalmol. 2005;123(2):209\u201313.","journal-title":"Arch Ophthalmol."},{"issue":"2","key":"120_CR29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1076\/ceyr.17.2.132.5610","volume":"17","author":"JJ Plantner","year":"1998","unstructured":"Plantner JJ, Smine A, Quinn TA. Matrix metalloproteinases and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous. Curr Eye Res. 1998;17(2):132\u201340.","journal-title":"Curr Eye Res."},{"issue":"4","key":"120_CR30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ajo.2005.04.017","volume":"140","author":"A Takano","year":"2005","unstructured":"Takano A, Hirata A, Inomata Y, Kawaji T, Nakagawa K, Nagata S, Tanihara H. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Am J Ophthalmol. 2005;140(4):654\u201360.","journal-title":"Am J Ophthalmol."},{"issue":"4","key":"120_CR31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/02713689608995835","volume":"15","author":"DJ Brown","year":"1996","unstructured":"Brown DJ, Bishop P, Hamdi H, Kenney MC. Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2. Curr Eye Res. 1996;15(4):439\u201345.","journal-title":"Curr Eye Res."},{"issue":"2","key":"120_CR32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jcp.10126","volume":"192","author":"S Monea","year":"2002","unstructured":"Monea S, Lehti K, Keski-Oja J, Mignatti P. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J Cell Physiol. 2002;192(2):160\u201370.","journal-title":"J Cell Physiol."},{"issue":"4","key":"120_CR33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajo.2005.12.034","volume":"141","author":"A Gandorfer","year":"2006","unstructured":"Gandorfer A, Kampik A. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Am J Ophthalmol. 2006;141(4):784\u20135.","journal-title":"Am J Ophthalmol."},{"issue":"1","key":"120_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(01)00015-5","volume":"21","author":"JM Sivak","year":"2002","unstructured":"Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002;21(1):1\u201314.","journal-title":"Prog Retin Eye Res."},{"issue":"4\u20135","key":"120_CR35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/02713680490516747","volume":"29","author":"F Staubach","year":"2004","unstructured":"Staubach F, Nober V, Janknecht P. Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin. Curr Eye Res. 2004;29(4\u20135):261\u20138.","journal-title":"Curr Eye Res."},{"issue":"3","key":"120_CR36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00417-008-1000-7","volume":"247","author":"M Hermel","year":"2009","unstructured":"Hermel M, Prenner J, Alabdulrazza M, Dailey W, Hartzer M. Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo. Graefe\u2019s Arch Clin Exp Ophthalmol. 2009;247(3):331\u20134.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol."},{"issue":"4","key":"120_CR37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00417-006-0394-3","volume":"245","author":"J Sebag","year":"2007","unstructured":"Sebag J, Ansari RR, Suh KI. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol. 2007;245(4):576\u201380.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"2","key":"120_CR38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.03-0930","volume":"45","author":"A Gandorfer","year":"2004","unstructured":"Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Investig Ophthalmol Vis Sci. 2004;45(2):641\u20137.","journal-title":"Investig Ophthalmol Vis Sci."},{"issue":"2","key":"120_CR39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1167\/iovs.08-2185","volume":"50","author":"MD Smet De","year":"2009","unstructured":"De Smet MD, Valmaggia C, Zarranz-Ventura J, Willekens B. Microplasmin: ex vivo characterization of its activity in porcine vitreous. Invest Ophthalmol Vis Sci. 2009;50(2):814\u20139.","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"9","key":"120_CR40","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1167\/iovs.04-1517","volume":"46","author":"T Sakuma","year":"2005","unstructured":"Sakuma T, Tanaka M, Mizota A, Inoue J, Pakola S. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Invest Ophthalmol Vis Sci. 2005;46(9):3295\u20139.","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"120_CR41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.eye.6702931","volume":"22","author":"W Chen","year":"2008","unstructured":"Chen W, Huang X, Ma XW, Mo W, Wang WJ, Song HY. Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator. Eye. 2008;22(2):300\u20137.","journal-title":"Eye."},{"key":"120_CR42","unstructured":"De Smet MD, Gandorfer A, Stalmans P, et al. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI-I trial. Ophthalmology. 2009;116(7):1349\u201355, 1355.e1341\u20132."},{"issue":"7","key":"120_CR43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/IAE.0b013e3181e0970a","volume":"30","author":"P Stalmans","year":"2010","unstructured":"Stalmans P, Delaey C, de Smet MD, et al. Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial). Retina. 2010;30(7):1122\u20137.","journal-title":"Retina."},{"issue":"4","key":"120_CR44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ophtha.2009.11.005","volume":"117","author":"MS Benz","year":"2010","unstructured":"Benz MS, Packo KH, Gonzalez V, et al. A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy. Ophthalmology. 2010;117(4):791\u20137.","journal-title":"Ophthalmology."},{"issue":"7","key":"120_CR45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","volume":"367","author":"P Stalmans","year":"2012","unstructured":"Stalmans P, Benz MS, Gandorfer A, et al. Enzymatic vitreolysis with Ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367(7):606\u201315.","journal-title":"N Engl J Med."},{"key":"120_CR46","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/archopht.1992.01080220134035","volume":"110","author":"J Sebag","year":"1992","unstructured":"Sebag J, Buckingham B, Charles MA, Reiser K. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol. 1992;110:1472\u20139.","journal-title":"Arch Ophthalmol."},{"key":"120_CR47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00919101","volume":"231","author":"J Sebag","year":"1993","unstructured":"Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol. 1993;231:257\u201360.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"120_CR48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-6420(96)30716-1","volume":"103","author":"J Sebag","year":"1996","unstructured":"Sebag J. Diabetic Vitreopathy (Guest Editorial). Ophthalmology. 1996;103:205\u20136.","journal-title":"Ophthalmology."},{"issue":"11","key":"120_CR49","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1167\/iovs.11-8333","volume":"52","author":"J Sebag","year":"2011","unstructured":"Sebag J. Vitreoschisis in diabetic macular edema. Invest Ophthalmol Vis Sci. 2011;52(11):8455\u20136.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"120_CR50","doi-asserted-by":"crossref","unstructured":"Novack RL, Staurenghi G, Girach A, Narendran N, Tolentino M. Safety of intravitreal Ocriplasmin for focal vitreo-macular adhesion in patients with exudative age-related macular degeneration. Ophthalmology. 2014. doi: 10.1016\/j.ophtha.2014.10.006 .","DOI":"10.1016\/j.ophtha.2014.10.006"},{"key":"120_CR51","unstructured":"National Institute for Health and Care Excellence (NICE). Ocriplasmin for treating vitreomacular traction. London: National Institute for Health and Care Excellence (NICE); 2013. p. 52 (Technology appraisal guidance; no. 297)."},{"key":"120_CR52","doi-asserted-by":"crossref","unstructured":"Stalmans P: Pharmacologic vitreolysis with ocriplasmin\u2014clinical studies. In: Sebag J, editor. Vitreous\u2014in health and disease, Ch VI.E.2. New York: Springer; 2014.","DOI":"10.1007\/978-1-4939-1086-1_53"},{"key":"120_CR53","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamaophthalmol.2013.8258","volume":"132","author":"MD Tibbetts","year":"2014","unstructured":"Tibbetts MD, Reichel E, Witkin AJ. Vision loss after intravitreal Ocriplasmin: correlation of spectral-domain coherence tomography and electroretinography. JAMA Ophthalmol. 2014;132:487\u201390.","journal-title":"JAMA Ophthalmol."},{"key":"120_CR54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jamaophthalmol.2013.8142","volume":"132","author":"AT Fahim","year":"2014","unstructured":"Fahim AT, Khan NW, Johnson MW. Acute panretinal structural and functional abnormalities after intravitreous Ocriplasmin injection. JAMA Ophthalmol. 2014;132:484\u20136.","journal-title":"JAMA Ophthalmol."},{"issue":"4","key":"120_CR55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaophthalmol.2014.278","volume":"132","author":"JE Kim","year":"2014","unstructured":"Kim JE. Safety and complications of ocriplasmin: ocriplasmin, ocriplasmin; oh, how safe art thou? JAMA Ophthalmol. 2014;132(4):379\u201380.","journal-title":"JAMA Ophthalmol."},{"key":"120_CR56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2013-304219","volume":"98","author":"RP Singh","year":"2014","unstructured":"Singh RP, Li A, Bedi R, Srivastava S, Sears JE, Ehlers JP, et al. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol. 2014;98:356\u201360.","journal-title":"Br J Ophthalmol."},{"key":"120_CR57","unstructured":"Nudleman E, Ruby AAJ, Wolfe J. Ocriplasmin for vitreomacular adhesion: aftermarket experience and finding. Invest Ophthalmol Vis Sci. 2014 (ARVO);55:E-Abstract 301."},{"key":"120_CR58","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-8908-8","volume-title":"The vitreous: structure, function, and pathobiology","author":"J Sebag","year":"1989","unstructured":"Sebag J. The vitreous: structure, function, and pathobiology. New York: Springer; 1989."},{"key":"120_CR59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/978-1-4939-1086-1_53","volume-title":"Vitreous in health and disease","author":"P Stallmans","year":"2014","unstructured":"Stallmans P. Pharmacologic vitreolysis with ocriplasmin: clinical studies. In: Sebag J, editor. Vitreous in health and disease. New York: Springer; 2014. p. 853\u201361."}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-015-0120-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40259-015-0120-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-015-0120-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T05:55:01Z","timestamp":1598853301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40259-015-0120-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,27]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1007\/s40259-015-0120-y","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,27]]}}}